The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
Titel:
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
Auteur:
Stewart Coats, Andrew J. Srinivasan, Venkatesan Surendran, Jayaraman Chiramana, Haritha Vangipuram, Shankar R. K. G. Bhatt, Nirajkumar N. Jain, Minish Shah, Sandip Ali, Irfhan A. B. H. Fuang, Ho G. Hassan, Mohammed Z. M. Beadle, John Tilson, Julia Kirwan, Bridget-Anne Anker, Stefan D.